Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Changes in the modes of twin birth in Victoria, 1983-2015.

Liu YA, Davey MA, Lee R, Palmer KR, Wallace EM.

Med J Aust. 2019 Nov 12. doi: 10.5694/mja2.50402. [Epub ahead of print]

PMID:
31713879
2.

Pregnancy Prolongation After Eculizumab Use in Early-Onset Preeclampsia.

Lu AB, Lazarus B, Rolnik DL, Palmer KR.

Obstet Gynecol. 2019 Nov 4. doi: 10.1097/AOG.0000000000003570. [Epub ahead of print]

PMID:
31698377
3.

Prolong: a double-blind randomised placebo-controlled trial of broccoli sprout extract in women with early onset preeclampsia. A clinical trial protocol.

Langston-Cox AG, Marshall SA, Palmer KR, Wallace EM.

BMJ Open. 2019 Oct 17;9(10):e027493. doi: 10.1136/bmjopen-2018-027493.

4.

Mechanical methods for induction of labour.

de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M.

Cochrane Database Syst Rev. 2019 Oct 18;10:CD001233. doi: 10.1002/14651858.CD001233.pub3. [Epub ahead of print] Review.

5.

Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma.

Rowson S, Reddy M, Rolnik DL, Da Silva Costa F, Palmer KR.

Placenta. 2019 Oct;86:1-3. doi: 10.1016/j.placenta.2019.08.001. Epub 2019 Aug 7.

PMID:
31476387
6.

Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction.

Palmer KR, Mockler JC, Davies-Tuck ML, Miller SL, Goergen SK, Fahey MC, Anderson PJ, Groom KM, Wallace EM.

BMJ Open. 2019 Jun 22;9(6):e028243. doi: 10.1136/bmjopen-2018-028243.

7.

Management of intrahepatic cholestasis in pregnancy.

Palmer KR, Xiaohua L, Mol BW.

Lancet. 2019 Mar 2;393(10174):853-854. doi: 10.1016/S0140-6736(18)32323-7. Epub 2019 Feb 14. No abstract available.

8.

Current and emerging pharmacotherapy for emergency management of preeclampsia.

Cox AG, Marshall SA, Palmer KR, Wallace EM.

Expert Opin Pharmacother. 2019 Apr;20(6):701-712. doi: 10.1080/14656566.2019.1570134. Epub 2019 Feb 1. Review.

PMID:
30707633
9.

Comparison of maternal and perinatal outcomes in women with super obesity based on planned mode of delivery.

Parambi A, Davies-Tuck M, Palmer KR.

Aust N Z J Obstet Gynaecol. 2019 Jun;59(3):387-393. doi: 10.1111/ajo.12870. Epub 2018 Aug 13.

PMID:
30101533
10.

Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction.

Pedroso MA, Palmer KR, Hodges RJ, Costa FDS, Rolnik DL.

Rev Bras Ginecol Obstet. 2018 May;40(5):287-293. doi: 10.1055/s-0038-1660777. Epub 2018 Jun 18. Review.

11.

Accurately Predicting the Risk of Serious Maternal Morbidity in Preterm Preeclampsia: Can It Be Done?

Palmer KR, Tong S.

Hypertension. 2018 Apr;71(4):569-571. doi: 10.1161/HYPERTENSIONAHA.117.10442. Epub 2018 Feb 12. No abstract available.

PMID:
29440329
12.

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.

Hannan NJ, Brownfoot FC, Cannon P, Deo M, Beard S, Nguyen TV, Palmer KR, Tong S, Kaitu'u-Lino TJ.

Sci Rep. 2017 May 12;7(1):1819. doi: 10.1038/s41598-017-01993-w.

13.

Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.

Palmer KR, Tong S, Kaitu'u-Lino TJ.

Mol Hum Reprod. 2017 Feb 10;23(2):69-78. doi: 10.1093/molehr/gaw077. Review.

PMID:
27986932
14.

Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.

Ye L, Gratton A, Hannan NJ, Cannon P, Deo M, Palmer KR, Tong S, Kaitu'u-Lino TJ, Brownfoot FC.

Placenta. 2016 Dec;48:110-118. doi: 10.1016/j.placenta.2016.10.013. Epub 2016 Oct 21.

PMID:
27871461
15.

Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.

Palmer KR, Kaitu'u-Lino TJ, Cannon P, Tuohey L, De Silva MS, Varas-Godoy M, Acuña S, Galaz J, Tong S, Illanes SE.

J Matern Fetal Neonatal Med. 2017 Mar;30(6):635-639. doi: 10.1080/14767058.2016.1182975. Epub 2016 May 16.

PMID:
27124553
16.

Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.

Palmer KR, Tong S, Tuohey L, Cannon P, Ye L, Hannan NJ, Brownfoot FC, Illanes SE, Kaitu'u-Lino TJ.

Biol Reprod. 2016 Mar;94(3):59. doi: 10.1095/biolreprod.115.134460. Epub 2016 Jan 27.

PMID:
26819475
17.

Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.

Palmer KR, Kaitu'u-Lino TJ, Hastie R, Hannan NJ, Ye L, Binder N, Cannon P, Tuohey L, Johns TG, Shub A, Tong S.

Hypertension. 2015 Dec;66(6):1251-9. doi: 10.1161/HYPERTENSIONAHA.115.05883. Epub 2015 Sep 28.

PMID:
26416849
18.

Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.

Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewelyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF.

Lancet. 2015 Jul 11;386(9989):137-44. doi: 10.1016/S0140-6736(14)61999-1. Epub 2015 May 5.

PMID:
25956718
19.

Poor outcomes in hospitalized patients with gastrointestinal bleeding: impact of baseline risk, bleeding severity, and process of care.

Jairath V, Thompson J, Kahan BC, Daniel R, Hearnshaw SA, Travis SP, Murphy MF, Palmer KR, Logan RF.

Am J Gastroenterol. 2014 Oct;109(10):1603-12. doi: 10.1038/ajg.2014.263. Epub 2014 Aug 26.

PMID:
25155225
20.

Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial.

Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, Dyer C, Stokes EA, Llewelyn C, Bailey AA, Dallal H, Everett SM, James MW, Stanley AJ, Church N, Darwent M, Greenaway J, Le Jeune I, Reckless I, Campbell HE, Meredith S, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF.

Transfus Med Rev. 2013 Jul;27(3):146-53. doi: 10.1016/j.tmrv.2013.04.001. Epub 2013 May 22.

21.

National audit of the use of surgery and radiological embolization after failed endoscopic haemostasis for non-variceal upper gastrointestinal bleeding.

Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Dore CJ, Travis SP, Murphy MF, Palmer KR.

Br J Surg. 2012 Dec;99(12):1672-80. doi: 10.1002/bjs.8932. Epub 2012 Sep 28.

PMID:
23023268
22.

Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom.

Jairath V, Kahan BC, Stanworth SJ, Logan RF, Hearnshaw SA, Travis SP, Palmer KR, Murphy MF.

Transfusion. 2013 May;53(5):1069-76. doi: 10.1111/j.1537-2995.2012.03849.x. Epub 2012 Aug 15.

PMID:
22897615
23.

Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study.

Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Doré CJ, Travis SP, Murphy MF, Palmer KR.

Endoscopy. 2012 Aug;44(8):723-30. doi: 10.1055/s-0032-1309736. Epub 2012 Jul 2.

PMID:
22752889
24.

Acute upper gastrointestinal bleeding: identifying low risk patients.

Logan RF, Hearnshaw S, Lowe D, Travis SP, Murphy MS, Palmer KR.

Gut. 2012 Nov;61(11):1641. Epub 2012 Mar 2. No abstract available.

PMID:
22387528
25.

MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.

Kaitu'u-Lino TJ, Palmer KR, Whitehead CL, Williams E, Lappas M, Tong S.

Am J Pathol. 2012 Mar;180(3):888-94. doi: 10.1016/j.ajpath.2011.11.014. Epub 2012 Jan 31.

PMID:
22296769
26.

Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset pre-eclampsia? A retrospective study.

Weiler J, Tong S, Palmer KR.

PLoS One. 2011;6(10):e26937. doi: 10.1371/journal.pone.0026937. Epub 2011 Oct 28.

27.

Scope for improvement: a toolkit for improving the upper gastrointestinal bleeding service.

Palmer KR.

Frontline Gastroenterol. 2011 Jul;2(3):141-143. doi: 10.1136/flgastro-2011-100009. Epub 2011 May 27. No abstract available.

28.

Mortality from acute upper gastrointestinal bleeding in the United kingdom: does it display a "weekend effect"?

Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Travis SP, Murphy MF, Palmer KR.

Am J Gastroenterol. 2011 Sep;106(9):1621-8. doi: 10.1038/ajg.2011.172. Epub 2011 May 24.

PMID:
21606977
29.

Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia.

Whitehead CL, Palmer KR, Nilsson U, Gao Y, Saglam B, Lappas M, Tong S.

BJOG. 2011 Sep;118(10):1268-71. doi: 10.1111/j.1471-0528.2011.02962.x. Epub 2011 May 18.

30.

Red blood cell transfusion practice in patients presenting with acute upper gastrointestinal bleeding: a survey of 815 UK clinicians.

Jairath V, Kahan BC, Logan RF, Travis SP, Palmer KR, Murphy MF.

Transfusion. 2011 Sep;51(9):1940-8. doi: 10.1111/j.1537-2995.2011.03119.x. Epub 2011 Mar 24.

PMID:
21585395
31.

Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit.

Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR.

Gut. 2011 Oct;60(10):1327-35. doi: 10.1136/gut.2010.228437. Epub 2011 Apr 13.

PMID:
21490373
32.

The T1R2/T1R3 sweet receptor and TRPM5 ion channel taste targets with therapeutic potential.

Sprous D, Palmer KR.

Prog Mol Biol Transl Sci. 2010;91:151-208. doi: 10.1016/S1877-1173(10)91006-5. Review.

PMID:
20691962
33.

Inspiratory flow rate, not type of incentive spirometry device, influences chest wall motion in healthy individuals.

Chang AT, Palmer KR, McNaught J, Thomas PJ.

Physiother Theory Pract. 2010 Aug;26(6):385-92. doi: 10.3109/09593980903423210.

PMID:
20658924
34.

Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding.

Hearnshaw SA, Logan RF, Palmer KR, Card TR, Travis SP, Murphy MF.

Aliment Pharmacol Ther. 2010 Jul;32(2):215-24. doi: 10.1111/j.1365-2036.2010.04348.x. Epub 2010 May 5.

35.

Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit.

Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR.

Gut. 2010 Aug;59(8):1022-9. doi: 10.1136/gut.2008.174599. Epub 2010 Mar 31.

PMID:
20357318
36.

The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.

Lees CW, Ali AI, Thompson AI, Ho GT, Forsythe RO, Marquez L, Cochrane CJ, Aitken S, Fennell J, Rogers P, Shand AG, Penman ID, Palmer KR, Wilson DC, Arnott ID, Satsangi J.

Aliment Pharmacol Ther. 2009 Feb 1;29(3):286-97. doi: 10.1111/j.1365-2036.2008.03882.x.

37.

The use of adalimumab in the management of refractory Crohn's disease.

Ho GT, Smith L, Aitken S, Lee HM, Ting T, Fennell J, Lees CW, Palmer KR, Penman ID, Shand AG, Arnott ID, Satsangi J.

Aliment Pharmacol Ther. 2008 Feb 15;27(4):308-15. Epub 2007 Dec 7.

38.

Multiple liver lesions in a smoker.

Sharkey J, Palmer KR, Arnott ID, Glancy S.

Gut. 2007 Oct;56(10):1336, 1352. No abstract available.

39.

Complications of gastrointestinal endoscopy.

Palmer KR.

Gut. 2007 Apr;56(4):456-7. Review. No abstract available.

40.

Diagnostic and therapeutic endoscopy.

Church NI, Palmer KR.

Curr Opin Gastroenterol. 1999 Nov;15(6):504-8.

PMID:
17023997
41.

Endoscopic transpapillary stenting of pancreatic duct disruption.

Brennan PM, Stefaniak T, Palmer KR, Parks RW.

Dig Surg. 2006;23(4):250-4. Epub 2006 Aug 28. Erratum in: Dig Surg. 2006;23(5-6):369.

PMID:
16943673
42.

Validity of the Rockall scoring system after endoscopic therapy for bleeding peptic ulcer: a prospective cohort study.

Church NI, Dallal HJ, Masson J, Mowat NA, Johnston DA, Radin E, Turner M, Fullarton G, Prescott RJ, Palmer KR.

Gastrointest Endosc. 2006 Apr;63(4):606-12. Epub 2006 Jan 4.

PMID:
16564860
43.

The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues.

Masters SL, Yao S, Willson TA, Zhang JG, Palmer KR, Smith BJ, Babon JJ, Nicola NA, Norton RS, Nicholson SE.

Nat Struct Mol Biol. 2006 Jan;13(1):77-84. Epub 2005 Dec 20.

PMID:
16369487
44.

Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia.

Masters SL, Palmer KR, Stevenson WS, Metcalf D, Viney EM, Sprigg NS, Alexander WS, Nicola NA, Nicholson SE.

Mol Cell Biol. 2005 Jul;25(13):5639-47.

45.

Backbone 1H, 13C and 15N assignments of the 25 kDa SPRY domain-containing SOCS box protein 2 (SSB-2).

Yao S, Masters SL, Zhang JG, Palmer KR, Babon JJ, Nicola NA, Nicholson SE, Norton RS.

J Biomol NMR. 2005 Jan;31(1):69-70. No abstract available.

PMID:
15692743
46.

A randomized trial comparing heater probe plus thrombin with heater probe plus placebo for bleeding peptic ulcer.

Church NI, Dallal HJ, Masson J, Mowat NA, Johnston DA, Radin E, Turner M, Fullarton G, Prescott RJ, Palmer KR.

Gastroenterology. 2003 Aug;125(2):396-403.

PMID:
12891541
47.

Ulcers and nonvariceal bleeding.

Church NI, Palmer KR.

Endoscopy. 2003 Jan;35(1):22-6. Review.

PMID:
12510222
48.
49.

Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial.

Mitchell SA, Mee AS, Smith GD, Palmer KR, Chapman RW.

Aliment Pharmacol Ther. 2002 Jun;16(6):1187-95.

50.

Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease.

Smith GD, Watson R, Roger D, McRorie E, Hurst N, Luman W, Palmer KR.

J Adv Nurs. 2002 Apr;38(2):152-60.

PMID:
11940128

Supplemental Content

Loading ...
Support Center